Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abivax S.A.

81.03
-0.6100-0.75%
Post-market: 80.55-0.4800-0.59%18:50 EDT
Volume:578.72K
Turnover:46.79M
Market Cap:5.96B
PE:-25.49
High:82.13
Open:82.00
Low:79.95
Close:81.64
52wk High:82.13
52wk Low:4.77
Shares:73.57M
Float Shares:38.77M
Volume Ratio:0.48
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1785
EPS(LYR):-2.8941
ROE:-196.12%
ROA:-48.60%
PB:-773.94
PE(LYR):-28.00

Loading ...

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Aug 25

Abivax Sa : Piper Sandler Raises Target Price to $112 From $70

THOMSON REUTERS
·
Jul 29

Abivax price target raised to $112 from $70 at Piper Sandler

TIPRANKS
·
Jul 29

Abivax Closes $747.5 Million Offering of American Depositary Shares

MT Newswires Live
·
Jul 29

LifeSci Capital Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jul 27

Abivax prices 10.2M ADSs at $64.00 in underwritten public offering

TIPRANKS
·
Jul 24

Stock Track | Abivax S.A. Surges 5.54% Pre-market on Positive Phase 3 Results for Ulcerative Colitis Drug

Stock Track
·
Jul 24

Stock Track | Abivax Soars 5.67% as Ulcerative Colitis Drug Shows Promising Phase 3 Results

Stock Track
·
Jul 24

BUZZ-Abivax hits record high after inflammatory bowel disease drug trial data

Reuters
·
Jul 24

Abivax Shares Surge After Ulcerative Colitis Treatment Meets Primary Endpoint in Two Phase 3 Trials

MT Newswires Live
·
Jul 23

Abivax price target raised to $101 from $45 at LifeSci Capital

TIPRANKS
·
Jul 23

Stock Track | Abivax Skyrockets 547% on Positive Phase 3 Results for Ulcerative Colitis Treatment

Stock Track
·
Jul 23

Stock Track | Abivax S.A. Skyrockets 547% on Breakthrough Bowel Disease Treatment Results and Analyst Upgrades

Stock Track
·
Jul 23

Why Is Abivax Stock (ABVX) Up 490% Today?

TIPRANKS
·
Jul 23

US Stock Futures Edge Higher in Wednesday's Premarket Ahead of Housing, Oil Data

MT Newswires Live
·
Jul 23

U.S. Stocks to Watch: Tesla, Alphabet, Texas Instruments, SAP, Enphase, GoPro, Abivax, and More

Dow Jones
·
Jul 23

Stock Track | Abivax Skyrockets 420% in Pre-market on Breakthrough Bowel Disease Treatment Results

Stock Track
·
Jul 23

Abivax Skyrocketed 410% Premarket After Positive Late-Stage Study Results for Its Bowel Disease Treatment

THOMSON REUTERS
·
Jul 23

Abivax SA – American Depositary Shares trading halted, news pending

TIPRANKS
·
Jul 23

Citizens JMP healthcare analysts hold an analyst/industry conference call

TIPRANKS
·
Jul 10